IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $326,987 | +5.1% | 6,972 | -5.4% | 0.11% | +3.8% |
Q2 2023 | $311,025 | -55.1% | 7,372 | -62.0% | 0.11% | -57.1% |
Q1 2023 | $692,045 | -9.3% | 19,385 | 0.0% | 0.25% | -27.6% |
Q4 2022 | $763,381 | -15.7% | 19,385 | -2.5% | 0.34% | -25.4% |
Q3 2022 | $906,000 | +58.1% | 19,885 | +27.5% | 0.46% | +56.5% |
Q2 2022 | $573,000 | -10.3% | 15,593 | 0.0% | 0.29% | -0.7% |
Q1 2022 | $639,000 | +37.1% | 15,593 | 0.0% | 0.29% | +54.7% |
Q4 2021 | $466,000 | -14.3% | 15,593 | 0.0% | 0.19% | +2.2% |
Q3 2021 | $544,000 | -10.2% | 15,593 | 0.0% | 0.19% | -16.2% |
Q2 2021 | $606,000 | -8.5% | 15,593 | 0.0% | 0.22% | -16.9% |
Q1 2021 | $662,000 | -27.9% | 15,593 | +4.9% | 0.27% | -30.1% |
Q4 2020 | $918,000 | +1.5% | 14,863 | -2.6% | 0.38% | -27.9% |
Q2 2020 | $904,000 | +16.2% | 15,263 | +2.7% | 0.53% | -21.0% |
Q1 2020 | $778,000 | -13.2% | 14,863 | 0.0% | 0.67% | -16.9% |
Q4 2019 | $896,000 | +6.4% | 14,863 | 0.0% | 0.81% | -7.7% |
Q3 2019 | $842,000 | +84100.0% | 14,863 | 0.0% | 0.87% | +1932.6% |
Q1 2019 | $1,000 | – | 14,863 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |